Newamsterdam Pharma NV (NAMS US)

NewAmsterdam Pharma Company N.V. operates as a late-stage clinical biopharmaceutical company. The company focuses on the development of oral small molecule therapies for cardiovascular and other metabolic diseases. The company serves patients in the US and Europe.